Phone:
+1 877 302 8632
Fax:
+1 888 205 9894 (Toll-free)
E-Mail:
orders@antibodies-online.com

Metastasis Associated 1 (MTA1) (Intermediate Domain) Peptide

MTA1 Reactivity: Human Host: Synthetic BP, BI
Catalog No. ABIN5685293
  • Target See all MTA1 products
    MTA1 (Metastasis Associated 1 (MTA1))
    Protein Region
    Intermediate Domain
    Origin
    Human
    Source
    • 5
    Synthetic
    Application
    Blocking Peptide (BP), BioImaging (BI)
    Characteristics
    MTA1 peptide corresponds to 10 amino acids near the intermediate domain of MTA1.
  • Application Notes
    MTA1 Peptide is used for blocking the activity of MTA1 antibody . The MTA1 antibody ships at 0.5 mg/mL and the MTA1 Peptide ships as a 100 μg pellet. When peptide is reconstituted in 200 μLwater, the concentration will be 0.5 mg/mL, identical to that of the antibody. The best starting ratio would be 1:1 (which means molar excess of peptide relative to antibody when identical volumes are mixed). Mix equal volume of peptide and antibody at the required dilution and leave at ambient temperature for 20 minutes. Then incubate and develop in parallel two blots: one with the antibody and one with the antibody which has been pre-absorbed with the provided peptide.
    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    MTA1 peptide is supplied as 100 µg of dried peptide. When the peptide is reconstituted in 200 µL water, the concentration will be 0.5 mg/mL.
    Storage
    -20 °C
    Storage Comment
    Store at -20°C. When reconstituted minimize freezing and thawing.
  • Target
    MTA1 (Metastasis Associated 1 (MTA1))
    Synonyms
    Tex22 Peptide, metastasis associated 1 Peptide, metastasis associated 1 L homeolog Peptide, MTA1 Peptide, Mta1 Peptide, mta1.L Peptide
    Gene ID
    9112
    NCBI Accession
    NP_004680
    OMIM
    115527080
    UniProt
    Q13330
You are here:
Support